Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» kidney cancer
kidney cancer
Aveo to pay $4m to settle investor fraud charges
Stat
Tue, 03/29/16 - 10:11 pm
Aveo Pharmaceuticals
tivozanib
kidney cancer
investors
Aveo’s kidney cancer drug submitted for approval in Europe
Bizjournals.com
Tue, 03/1/16 - 10:58 pm
Aveo Oncology
kidney cancer
tivozanib
Eisai scores FDA priority review for bigger Lenvima use in kidney cancer
Fierce Pharma
Wed, 01/20/16 - 08:40 am
Eisai
Lenvima
kidney cancer
FDA
priority review
Bristol-Myers nabs FDA priority review for new Opdivo use in kidney cancer
Fierce Pharma
Tue, 11/17/15 - 05:57 pm
Bristol-Myers Squibb
FDA
priority review
Opdivo
kidney cancer
Kidney Cancer Drug Boxing Match
Motley Fool
Mon, 10/5/15 - 09:17 am
kidney cancer
Bristol-Myers Squibb
Novartis
Exelixis
Opdivo
Cometriq
Afinitor
Cometriq Plays Wallflower As Opdivo's Dance Card Fills
Seeking Alpha
Mon, 09/28/15 - 08:23 am
Bristol-Myers Squibb
Opdivo
Cometriq
Exelixis
kidney cancer
Bristol's Opdivo boosts kidney cancer survival beyond two years
Yahoo/Reuters
Sat, 09/26/15 - 09:54 am
Bristol-Myers Squibb
Opdivo
kidney cancer
Novartis
Afinitor
Watch out, Afinitor. Bristol's 'breakthrough' Opdivo is coming for you
Fierce Pharma Marketing
Fri, 09/18/15 - 09:14 pm
Bristol-Myers Squibb
Afinitor
Opdivo
Novartis
kidney cancer
Bristol-Myers' Opdivo Gets Breakthrough Status for Kidney Cancer
NASDAQ.com
Wed, 09/16/15 - 09:42 am
Bristol-Myers Squibb
Opdivo
kidney cancer
breakthrough therapies
Exelixis Drug Slows Kidney Cancer In New Chance For Embattled Biotech
Forbes
Mon, 07/20/15 - 09:07 am
Exelixis
kidney cancer
Cometriq
Bristol-Myers flags early success for PhIII Opdivo study in kidney cancer
Fierce Biotech
Mon, 07/20/15 - 09:04 am
Bristol-Myers Squibb
Opdivo
kidney cancer
Aveo Subpoenaed by U.S. Regulator Over Kidney Cancer Drug
Bloomberg
Fri, 07/12/13 - 08:43 am
Aveo Pharmaceuticals
kidney cancer
SEC
tivozanib
Aveo defends kidney cancer drug rejected by the FDA
Boston Globe, MA
Wed, 06/12/13 - 09:15 am
kidney cancer
FDA
Aveo Oncology
tivozanib
FDA rejects Aveo kidney cancer drug, asks for additional trial
Reuters
Mon, 06/10/13 - 11:20 am
FDA
kidney cancer
Aveo Oncology
tivozanib
Threshold Pharmaceuticals Announces Data From Two Ongoing Phase 1/2 Trials of TH-302 at the 2013 ASCO Annual Meeting
Yahoo/MarketWire
Sun, 06/2/13 - 11:39 am
Threshold Pharmaceuticals
TH-302
Multiple Myeloma
gastrointestinal stromal tumors
renal cell carcinoma
kidney cancer
Roche immunotherapy shows response over range of cancers
Reuters
Thu, 05/16/13 - 10:22 am
Roche
immunotherapy
MPDL3280A
melanoma
lung cancer
kidney cancer
Aveo Screwed Up but Its Kidney Cancer Drug Is Real
TheStreet.com
Wed, 05/15/13 - 10:37 am
kidney cancer
Aveo Oncology
tivozanib
Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/6/13 - 09:12 am
kidney cancer
ONYX Pharmaceuticals
Bayer
Nexavar
Roche
Avastin
Inlyta
Sutent
Pfizer
Votrient
GSK
Afinitor
Novartis
BMS-936558
Bristol-Myers Squibb
tivozanib
Aveo Oncology
Aveo, Delcath FDA Panel Live Blog
TheStreet.com
Thu, 05/2/13 - 10:52 am
FDA
advisory panels
tivozanib
Delcath
Aveo Oncology
kidney cancer
Melblez
Aveo Kidney Cancer Drug May Need More Study, FDA Says
Bloomberg
Tue, 04/30/13 - 09:46 am
kidney cancer
FDA
Aveo Pharmaceuticals
tivozanib
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »